These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3441572)
41. [Genetic problems in neurologic diseases--consulting aspects]. Berg K Nord Med; 1971 May; 85(21):670-1. PubMed ID: 5581420 [No Abstract] [Full Text] [Related]
42. [Epidemiology of progressive muscular dystrophy in selected regions of Poland]. Stepniak U Neurol Neurochir Pol; 1985; 19(5):369-74. PubMed ID: 3831791 [TBL] [Abstract][Full Text] [Related]
43. Genetic counselling for neurological and psychic diseases. I. Data on counsellees and their pre- and post-counselling family planning. Christodorescu D Neurol Psychiatr (Bucur); 1980; 18(4):269-79. PubMed ID: 7466272 [No Abstract] [Full Text] [Related]
45. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy]. Beckmann R; Scheuerbrandt G Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067 [TBL] [Abstract][Full Text] [Related]
46. [Clinical and genetic heterogeneity of limb-girdle muscular dystrophy]. Kozłowska M Neurol Neurochir Pol; 1995; 29(4):569-75. PubMed ID: 8544936 [TBL] [Abstract][Full Text] [Related]
47. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study. Hutton EM; Thompson MW Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964 [TBL] [Abstract][Full Text] [Related]
48. Molecular genetic approaches to the study of the nervous system. Hayden MR; Nichols JL Dev Neurosci; 1983-1984; 6(4-5):189-214. PubMed ID: 6083860 [TBL] [Abstract][Full Text] [Related]
49. Experience with DNA analysis in Duchenne and Becker muscular dystrophy families in NSW. Morgan G; Donald JA; Chen J; Serravalle S; Colley P; Denton MJ Aust Paediatr J; 1988; 24 Suppl 1():98-9. PubMed ID: 3202741 [TBL] [Abstract][Full Text] [Related]
50. [Genetic counseling in myotonia and muscular dystrophy]. Becker PE Internist (Berl); 1978 Aug; 19(8):475-81. PubMed ID: 357337 [No Abstract] [Full Text] [Related]
51. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels. Muir WA; Knoke J; Martin A; Vignos P; McErlean A Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600 [TBL] [Abstract][Full Text] [Related]
54. An introduction to the molecular genetics of neurological disease. Recent advances. Rosenberg RN Arch Neurol; 1993 Nov; 50(11):1123-8. PubMed ID: 8215973 [No Abstract] [Full Text] [Related]
55. [Principal aspects of research in primary myopathies with the recessive X-linked type of inheritance (review)]. Grinio LP Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(4):124-33. PubMed ID: 7046305 [No Abstract] [Full Text] [Related]
56. [Medical genetic consultations in hereditary diseases of the nervous system]. Markova ED Med Sestra; 1980 Jan; 39(1):43-4. PubMed ID: 6898789 [No Abstract] [Full Text] [Related]
57. Genetic counseling of isolated carriers of Duchenne muscular dystrophy. Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437 [TBL] [Abstract][Full Text] [Related]
58. Guidelines for genetic counselling for neurological diseases: ethical issues. Petrini C Minerva Med; 2011 Apr; 102(2):149-59. PubMed ID: 21483402 [TBL] [Abstract][Full Text] [Related]